378 related articles for article (PubMed ID: 23756256)
1. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
Lee SH; Lee YS; Hong YG; Kang CS
APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
3. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
4. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
5. AKT2 expression in histopathologic grading and recurrence of meningiomas.
Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
[TBL] [Abstract][Full Text] [Related]
6. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
[TBL] [Abstract][Full Text] [Related]
7. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
[TBL] [Abstract][Full Text] [Related]
8. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
Korshunov AG; Shishkina LV; Golanov AV
Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
[TBL] [Abstract][Full Text] [Related]
9. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
11. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
[TBL] [Abstract][Full Text] [Related]
12. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
14. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
Rushing EJ; Olsen C; Man YG
Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study.
Mittal S; Jain D; Roy S; Mehta VS
Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651
[TBL] [Abstract][Full Text] [Related]
17. Significance of cyclin D1 expression in meningiomas: a preliminary study.
Alama A; Barbieri F; Spaziante R; Bruzzo C; Dadati P; Dorcaratto A; Ravetti JL
J Clin Neurosci; 2007 Apr; 14(4):355-8. PubMed ID: 17240151
[TBL] [Abstract][Full Text] [Related]
18. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
19. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
[TBL] [Abstract][Full Text] [Related]
20. S100A5: a marker of recurrence in WHO grade I meningiomas.
Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]